InterWest

InterWest invests an average of about $7 - 15 million over the span of their involvement with each company in their portfolio. They invest in companies through the full range of venture investment stages, and investments may be staged over several rounds of financing. Although they generally begin their involvement in the early stages of a company's development, they pursue attractive opportunities based on their individual merits rather than their investment stage.

Farah Champsi

Managing Partner

Keval Desai

General Partner

Doug Fisher

Executive in Residence

Flip Gianos

General Partner Emeritus

W. Stephen Holmes

General Partner Emeritus

Gil Kliman

Managing Partner

Gilbert Kliman

Managing Partner

Khaled Nasr

General Partner and COO

Arnie Oronsky

Managing Partner

Arnold L. Oronsky

Managing Partner

Michelle Snyder

Advisor

Karen Wilson

CFO

Reza Zadno

Advisor

435 past transactions

Triposo

Venture Round in 2015
Triposo, Inc. develops interactive travel guides for the mobile devices. It offers country maps, and language and city guides. The company also provides background information on the country, culture, and history; descriptions; list of restaurants, bars, and nightclubs; hiking, biking, or relaxing activities information; and offline maps. Triposo, Inc. was founded in 2010 and is based in Amersfoort, the Netherlands. As of October 10, 2017, Triposo, Inc. operates as a subsidiary of Musement S.r.l.
Advanced Micro-Fabrication Equipment Inc. (中微半导体设备(上海)有限公司) is a Chinese global microfabrication equipment company serving customers in the semiconductor industry and relevant high-tech sectors. The company is a specialized supplier of key equipment for the production and development of micron-sized and nanoscale VLSI for the semiconductor industry in China and Asia. The company is focused on chemical vapor deposition and plasma etching products.

Fluidigm

Series D in 2005
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.

Centrexion Therapeutics

Private Placement in 2017
Centrexion Therapeutics is focused on developing new therapies for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.We aim to relieve the suffering associated with chronic pain by creating treatments that address the safety and efficacy gaps in the current treatment paradigm.

Carwoo

Series A in 2010
Carwoo is an online platform that enables its users to anonymously buy cars from dealers in their local area. Carwoo was launched in 2008 and is based in California.

Bivio Networks

Series A in 2000
Founded in 2000, Bivio Networks is dedicated to providing leading networking products that enable government agencies and service providers to control, monitor, and secure critical network infrastructure. A leader in cyber intelligence, cyber security and network control solutions, Bivio has deployed its products in a wide range of solutions. Bivio’s global customer base includes leading intelligence agencies, military organizations and service providers. Bivio is privately-held and is headquartered in the San Francisco Bay Area with office locations worldwide. Specialties Cyber Security, Cyber Intelligence, Deep Packet Inspection (DPI) Networking Systems, Mass Metadata Extraction and Analysis, Data Retention System, Cyber Investigation, network probe

C9 Inc.

Series A in 2007
C9 delivers predictive sales and marketing applications that increase revenue, generate more precise forecasts and mitigate pipeline risk. By combining data science with products that improve sales and marketing execution, C9 enables leading companies like Yahoo!, Pitney Bowes and Google to drive predictable growth. C9 is located in San Mateo and is backed by the Mayfield Fund, InterWest Partners and Leapfrog Ventures.

QuatRx Pharmaceuticals

Series E in 2007
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics. Its products include Osphena for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women. QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

The RealReal

Series D in 2015
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Damballa

Series D in 2011
As the experts in advanced threat protection, Damballa discovers active threats that bypass all security prevention layers. Damballa automatically identifies successful infections and pinpoints devices that represent the highest risk to a business. Our patent-pending solutions combine principles of data science and machine learning to discover threats without prior knowledge of them and regardless of device type, OS and threat vector. Damballa protects nearly a billion endpoints globally at enterprises in every major market and for the world’s largest ISP and telecommunications providers. For more information, visit www.damballa.com, or follow us on Twitter @DamballaInc. Watch an analyst interview with Brian Foster, CTO until June, 2015 , here: https://vimeo.com/129326008

TESARO

Series B in 2011
Founded in 2010, TESARO is a privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to leverage the experience and competencies of its management team to identify, acquire and develop promising drug candidates; and to commercialize safer and more effective products for the treatment and support of cancer patients. TESARO is developing rolapitant, a potent, selective neurokinin-1 receptor antagonist that has completed Phase 2 clinical testing for the prevention of chemotherapy induced nausea and vomiting, and is advancing its ALK inhibitor program for oncology indications. Phase 3 clinical testing of rolapitant is planned to commence during 2011 and the first ALK inhibitor clinical trial is targeted to begin in 2012. TESARO was co-founded by former executives of MGI PHARMA, an oncology and acute-care focused biopharmaceutical company that Eisai Co., Ltd. acquired in 2008 for $3.9 billion. TESARO is headquartered in Waltham, Massachusetts.

Motiva

Series D in 2002
Motiva, Inc. is the technology leader for global enterprise incentive management (EIM) software and services, enabling companies to create and manage flexible, highly targeted incentive programs that drive top-line and bottom-line results across the extended enterprise. The Motiva software solution allows businesses to rapidly align performance with strategic objectives for sales, services, channels, customers and suppliers. Founded in 1996, Motiva is headquartered in Pleasanton, California.

Bivio Networks

Venture Round in 2006
Founded in 2000, Bivio Networks is dedicated to providing leading networking products that enable government agencies and service providers to control, monitor, and secure critical network infrastructure. A leader in cyber intelligence, cyber security and network control solutions, Bivio has deployed its products in a wide range of solutions. Bivio’s global customer base includes leading intelligence agencies, military organizations and service providers. Bivio is privately-held and is headquartered in the San Francisco Bay Area with office locations worldwide. Specialties Cyber Security, Cyber Intelligence, Deep Packet Inspection (DPI) Networking Systems, Mass Metadata Extraction and Analysis, Data Retention System, Cyber Investigation, network probe

Scale Eight

Series D in 2002
Scale Eight is an internet company. It offers virtually limitless storage capacity, allowing companies to grow their online offerings. Scale Eight delivers file storage solutions technology through its global storage service and in a family of network-attached storage products. Scale Eight was founded by Josh Coates and is located in San Francisco, California.

Scale Eight

Series C in 2001
Scale Eight is an internet company. It offers virtually limitless storage capacity, allowing companies to grow their online offerings. Scale Eight delivers file storage solutions technology through its global storage service and in a family of network-attached storage products. Scale Eight was founded by Josh Coates and is located in San Francisco, California.

KAI Pharmaceuticals

Series A in 2003
KAI Pharmaceuticals is a drug discovery and development company with multiple, novel clinical-stage programs in the areas of cardiovascular disease, kidney disease and pain. KAI lead product candidate, KAI-9803, is currently in a Phase 2b study (PROTECTION AMI) designed to assess the effect of KAI-9803 on reducing myocardial injury in heart attack patients. KAI second core program, KAI-4169 for the treatment of secondary hyperparathyroidism (SHPT) in kidney disease patients, is expected to enter human clinical trials in 2010. KAI also has an ongoing pain program, KAI-1678, which is currently in Phase 2a testing.

InVisage Technologies

Series E in 2014
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.

Paracor Medical

Series C in 2004
Paracor Medical is an innovative medical device company focused on providing unique, technology-driven solutions for the treatment of heart failure. Founded in 1999, Paracor was established to pursue new and innovative ways to treat heart failure (HF) that would not require the patient to undergo open chest surgery. Paracor engineers recognized that a mechanical approach to reducing the workload of a failing, diseased heart muscle could be a new and effective solution.

Aryaka

Private Placement in 2019
[Aryaka](http://www.aryaka.com)'s Global SD-WAN provides optimized, software-defined network connectivity and application acceleration to globally distributed enterprises. Aryaka’s services have over 10 million users across more than 4,000 sites. Leading brands such as Skullcandy, Air China, Freescale Semiconductor, and ThoughtWorks, as well as partners such as Microsoft Azure, AWS, Intelisys, and SK Broadband, have all chosen Aryaka for their enterprise-grade networking needs.

Totango

Series D in 2018
Totango, Inc. develops an enterprise grade customer success platform that allows users to connect their customers’ data, monitor health changes, and engage their customers. The company offers Customer Success Centre, a solution for customer engagement; Zoe, a solution for enterprise impact; and DNA-CX, a solution for multidimensional customer context in real-time. Its solutions include voice of the customer, customer onboarding, customer adoption, customer renewal, and customer escalation. The company was founded in 2010 and is based in Redwood City, California. Totango, Inc. operates as a subsidiary of Totango Ltd.

Doximity

Series A in 2011
Founded in 2011, Doximity connects physicians and clinicians to make them more successful and productive. It is the largest professional medical network with over 70 percent of all U.S. physicians as members. The network enables medical professionals to communicate with colleagues and patients, and to share their perspectives on the latest health care trends and research. Doximity is based in San Francisco and was created by the founders of Epocrates and Rock Health. To learn more, visit www.doximity.com

APT Pharmaceuticals

Series B in 2008
APT Pharmaceuticals is a drug development company focused on repurposing well-characterized drugs for under-served populations. APT’s initial focus is on the pulmonary delivery of treatments for serious lung diseases.

Obalon Therapeutics

Series D in 2015
Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology. Located in San Diego, California, the technical team at Obalon has a long history of working closely with leading clinicians to develop innovative medical products that revolutionize the treatment of chronic disease. As a company, they believe in the fundamental value of imagination and invention, combined with rigorous testing and analysis, to ensure the highest levels of safety and performance. The result is a user-focused approach that deploys the power of advanced technological thinking to support clinical treatment objectives. It was founded in 2008.

ReVision Optics

Series D in 2010
ReVision Optics, Inc. designs, manufactures, and delivers implantable products for the treatment of presbyopia. It offers PRESBYLENS Corneal Inlay, a refractive surgery solution to correct vision lost by the natural aging process called presbyopia. The company serves the ophthalmology professionals. ReVision Optics, Inc. was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in 2005. The company was founded in 1996 and is based in Lake Forest, California.

KAI Pharmaceuticals

Series B in 2006
KAI Pharmaceuticals is a drug discovery and development company with multiple, novel clinical-stage programs in the areas of cardiovascular disease, kidney disease and pain. KAI lead product candidate, KAI-9803, is currently in a Phase 2b study (PROTECTION AMI) designed to assess the effect of KAI-9803 on reducing myocardial injury in heart attack patients. KAI second core program, KAI-4169 for the treatment of secondary hyperparathyroidism (SHPT) in kidney disease patients, is expected to enter human clinical trials in 2010. KAI also has an ongoing pain program, KAI-1678, which is currently in Phase 2a testing.

AccelChip

Series B in 2003
AccelChip, Inc. provides algorithmic synthesis solutions for digital signal processing (DSP) design. The company develops and markets design tools, integrated verification flows, and parametric intellectual property toolkits that automate the development and implementation of DSP algorithms in field programmable gate-arrays and application-specific integrated circuits. AccelChip, Inc. was formerly known as Mach Design Systems, Inc.

Damballa

Series E in 2014
As the experts in advanced threat protection, Damballa discovers active threats that bypass all security prevention layers. Damballa automatically identifies successful infections and pinpoints devices that represent the highest risk to a business. Our patent-pending solutions combine principles of data science and machine learning to discover threats without prior knowledge of them and regardless of device type, OS and threat vector. Damballa protects nearly a billion endpoints globally at enterprises in every major market and for the world’s largest ISP and telecommunications providers. For more information, visit www.damballa.com, or follow us on Twitter @DamballaInc. Watch an analyst interview with Brian Foster, CTO until June, 2015 , here: https://vimeo.com/129326008

Platform Solutions

Series B in 2004
Platform Solutions, Inc. develops Open Mainframe computers compatible with a set of datacenter environments and operating systems. It offers Open Mainframe servers, Open Systems servers, and NEC D-Series storage arrays. The company's System64 product line consolidates z/OS, Windows, and Linux operating system in one secure and reliable operating environment based on Intel Itanium 2 processor technology. Platform Solutions has a strategic partnership with T3 Technologies. The company was founded in 1999 and is based in Sunnyvale, California. As of June 30, 2008, Platform Solutions, Inc. operates as a subsidiary of International Business Machines Corp.

Flurry

Series C in 2010
Flurry is an application that provides analytics for businesses to monitor the trends and habits of mobile users across multiple mobile applications. Flurry’s mobile analytics solution enables businesses to understand how consumers interact with their mobile applications. Over 125,000 companies use Flurry’s analytics platform in more than 400,000 applications to measure audience reach, engagement, retention, conversions, revenue, and more. The service is completely free, takes just five minutes for basic integration, and is continuously updated with the industry's advanced features. Flurry Analytics is available for iOS, Android, Windows Phone, HTML5, hybrid apps, mobile/web, Blackberry, and JavaME.

Metro Optix

Series B in 2000
Metro-Optix develops hardware for telecommunications companies that want to transition from circuit-based services to cell- and packet-based services. The hardware essentially reduces the number of hardware boxes needed, such as routers, which the networks feed into.

OPAL

Series A in 2014
Opal is a marketing collaboration platform for modern marketing teams. Working in Opal helps teams align on strategy, create campaigns with confidence, streamline the reviews process, improve the facilitation of content, and seamlessly integrate with a team’s preferred distribution method. The Opal Platform tears down silos, reduces complexity, and connects teams across the enterprise for winning results. It was founded in 2011 and is headquartered in Portland, Oregon.

Convey Computer

Series A in 2007
Convey Computer offers a hybrid core computer for the oil and gas, financial analytics, and bioinformatics markets. The comp[any delivers decades of experience and intellectual assets to performance problem-solving. Its executive and design teams all come from successful backgrounds of building computer companies, most notably Convex Computer Corporation and Hewlett-Packard.

Flurry

Series D in 2013
Flurry is an application that provides analytics for businesses to monitor the trends and habits of mobile users across multiple mobile applications. Flurry’s mobile analytics solution enables businesses to understand how consumers interact with their mobile applications. Over 125,000 companies use Flurry’s analytics platform in more than 400,000 applications to measure audience reach, engagement, retention, conversions, revenue, and more. The service is completely free, takes just five minutes for basic integration, and is continuously updated with the industry's advanced features. Flurry Analytics is available for iOS, Android, Windows Phone, HTML5, hybrid apps, mobile/web, Blackberry, and JavaME.
Aspreva Pharmaceuticals Corp is an emerging pharmaceutical company headquartered in Victoria, British Columbia focused on identifying, developing and commercializing new indications for approved drugs and drug candidates for underserved patient populations. Their strategy, which they call “indication partnering”, is to collaborate with pharmaceutical and biopharmaceutical companies to pursue new indication approvals which lie beyond their strategic focus.

Eiger BioPharmaceuticals

Series A in 2009
Eiger BioPharmaceuticals is a privately held biotechnology company that develops a novel antiviral therapy for Hepatitis Delta, a life-threatening, Orphan Disease with high unmet medical need and no approved therapy. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Its strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients.

Potenza Therapeutics

Venture Round in 2016
Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune system to seek out, recognize and destroy tumors through a diversity of mechanisms that influence tumor immunity. It was founded in 2014 and headquartered in Cambridge, Massachusetts.

Participate Systems

Series D in 2002
Participate Systems provides outsourced online sales and customer support community solutions. The platform offers self-help solutions, software and management services, monthly and quarterly reports, and operating plans.

Gynesonics

Debt Financing in 2014
Gynesonics, Inc. designs and develops minimally invasive solutions for symptomatic uterine fibroids in women. The company offers Sonography-Guided Transcervical Fibroid Ablation (Sonata) System(The Sonata System) for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance serving customers in the European Union. Gynesonics, Inc. was founded in 2005 and is based in Redwood City, California with an additional location in Beuningen, the Netherlands.

Splice Machine

Venture Round in 2019
Splice Machine is a data platform that offers offline, and batch analysis, and powers intelligent applications for operational workflows. Splice Machine is disrupting the $30 billion traditional database world with the open-source dual-engine RDBMS for mixed operational and analytical workloads, powered by Apache Hadoop and Apache Spark. The Splice Machine RDBMS executes operational workloads on Apache HBase® and analytical workloads on Apache Spark. Splice Machine makes it easy to develop and create modern, real-time, scalable applications, or to offload operational and analytical workloads from expensive Oracle, Teradata, and Netezza systems. Typical use cases are ETL, operational reporting, or real-time applications.

Alfalight

Series B in 2000
Alfalight designs and manufactures high-power diode lasers for the industrial, defense, and telecommunications markets. Alfalight's innovative technology is based on advanced aluminum-free active region (ALFA) laser structures, enabling the manufacture of laser diodes with exceptionally high reliability and industry-leading efficiency.

Vidora

Seed Round in 2017
Vidora’s mission is to enhance the performance of Marketing and Product teams with No-Code Machine Learning. Our Machine Learning Platform, Cortex, allows teams to use predictions to continually optimize conversions and engagement, while providing end-to-end automation, allowing teams to create hundreds of predictions without the risk and cost of building in house. The largest global brands like Walmart, News Corp, and Discovery, leverage Cortex to intelligently learn from continuous streams of raw data to drive higher performance and automation across the enterprise.

InVisage Technologies

Series F in 2014
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.

Brecis Communications

Series C in 2003
BRECIS Communications, a communications company focused on leading-edge, broadband multi-service network processor architectures.

Biba

Series B in 2013
Biba Systems, Inc. offers a mobile-first business application that delivers conference calls and messaging services for businesses. It offers Biba, an integrated application that allows users to work with their teams; helps people get in touch instantly; and works across companies and devices. The company was founded in 2011 and is based in San Francisco, California. As of December 31, 2015, Biba Systems, Inc. operates as a subsidiary of Amazon.com, Inc..

C9 Inc.

Series C in 2010
C9 delivers predictive sales and marketing applications that increase revenue, generate more precise forecasts and mitigate pipeline risk. By combining data science with products that improve sales and marketing execution, C9 enables leading companies like Yahoo!, Pitney Bowes and Google to drive predictable growth. C9 is located in San Mateo and is backed by the Mayfield Fund, InterWest Partners and Leapfrog Ventures.

Gynesonics

Private Equity Round in 2018
Gynesonics, Inc. designs and develops minimally invasive solutions for symptomatic uterine fibroids in women. The company offers Sonography-Guided Transcervical Fibroid Ablation (Sonata) System(The Sonata System) for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance serving customers in the European Union. Gynesonics, Inc. was founded in 2005 and is based in Redwood City, California with an additional location in Beuningen, the Netherlands.

AGTC

Series B in 2012
Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, They use cutting-edge techniques to develop treatments for patients that have diseases caused by broken genes. They use gene therapy, which replaces those broken genes with normal functional genes, allowing a patient’s own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide.

Xirrus

Series E in 2012
Xirrus, Inc. manufactures and markets wireless networking products. The company offers indoor enclosures, snap-on covers, manufacturing rated enclosures, I-beam mounting kits, and outdoor enclosures; and products for improving security and minimizing the risk in deploying 802.11n wireless networks. It also provides Wi-Fi Array, a wireless networking device that integrates radios, high-gain directional antenna systems, multi-gigabit switches, controllers, firewalls, threat sensors, and embedded spectrum analyzers. In addition, the company offers power over gigabit Ethernet (PoGE) products; and a Management System, which offers a platform for the central management of a Wi-Fi Array network. It serves general enterprise, higher education, K-12 education, conference centers, hospitality, and manufacturing markets. The company was founded in 2004 and is headquartered in Thousand Oaks, California.

Ample Communications

Series C in 2004
As of September 25, 2007, Ample Communications, Inc. was acquired by Mindspeed Technologies, Inc. Ample Communications, Inc. develops silicon solutions for optimizing networking infrastructure. The company provides Ethernet MACs for increasing the performance of enterprise and wide-area networks. It offers integrated MACs that optimize Ethernet aggregation, as well as Gigabit Ethernet silicon solutions for the PC market. The company provides its products for various applications, including Ethernet switches and routers, Internet appliances, access devices in enterprise and metro applications, IPTV equipment, metro Ethernet, wireless/cellular backhaul, and Ethernet over SONET applications. Ample Communications, Inc. was founded in 2000 and is headquartered in Fremont, California.

Marketo

Series A in 2006
Marketing automation software

TESARO

Post in 2016
Founded in 2010, TESARO is a privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to leverage the experience and competencies of its management team to identify, acquire and develop promising drug candidates; and to commercialize safer and more effective products for the treatment and support of cancer patients. TESARO is developing rolapitant, a potent, selective neurokinin-1 receptor antagonist that has completed Phase 2 clinical testing for the prevention of chemotherapy induced nausea and vomiting, and is advancing its ALK inhibitor program for oncology indications. Phase 3 clinical testing of rolapitant is planned to commence during 2011 and the first ALK inhibitor clinical trial is targeted to begin in 2012. TESARO was co-founded by former executives of MGI PHARMA, an oncology and acute-care focused biopharmaceutical company that Eisai Co., Ltd. acquired in 2008 for $3.9 billion. TESARO is headquartered in Waltham, Massachusetts.

LongBoard

Series C in 2002
LongBoard, Inc. provides software solutions to enable the telecommunications carriers and service providers to deliver converged multimedia services. Its products include MediaRoam that provides telecommunications carriers with the ability to deliver differentiated Initiation Protocol Multimedia Subsystem enabled multimedia services across fixed and mobile networks; LongBoard Multimedia Application Platform, which provides a carrier-class software infrastructure for integrating IP-based communications; and OnePhone, a personal mobility application that automatically and transparently switches calls between cellular and WiFi networks. LongBoard, Inc. was formerly known as Persona Software, Inc. and it changed its name to LongBoard, Inc. in February 2006. The company was founded in 1999 and is based in Santa Clara, California with sales offices in London, the United Kingdom and Tokyo, Japan.

Platform Solutions

Series C in 2007
Platform Solutions, Inc. develops Open Mainframe computers compatible with a set of datacenter environments and operating systems. It offers Open Mainframe servers, Open Systems servers, and NEC D-Series storage arrays. The company's System64 product line consolidates z/OS, Windows, and Linux operating system in one secure and reliable operating environment based on Intel Itanium 2 processor technology. Platform Solutions has a strategic partnership with T3 Technologies. The company was founded in 1999 and is based in Sunnyvale, California. As of June 30, 2008, Platform Solutions, Inc. operates as a subsidiary of International Business Machines Corp.

AppMesh

Series A in 2013
AppMesh is building the next generation business platform for mobile devices. Founded by salesforce.com veterans, we believe that in the post-PC era business applications need to be personal, seamless, and intuitive.

RedShift BioAnalytics

Series A in 2006
RedShiftBio provides an infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality. It has developed a Microfluidic Modulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications. They started a new and developed MMS from the ground up specifically with the protein scientist in mind. The company was founded in 2005 and is headquartered in Burlington, Massachusetts.

Pivot3

Series B in 2005
Global Hyper-Converged Infrastructure

C9 Inc.

Series B in 2009
C9 delivers predictive sales and marketing applications that increase revenue, generate more precise forecasts and mitigate pipeline risk. By combining data science with products that improve sales and marketing execution, C9 enables leading companies like Yahoo!, Pitney Bowes and Google to drive predictable growth. C9 is located in San Mateo and is backed by the Mayfield Fund, InterWest Partners and Leapfrog Ventures.

Ribbon

Pre Seed Round in 2011
Ribbon Payments, Inc. operates a platform that allows users to sell and purchase products by sharing a unique showcase link. The company supports various types of products from physical and digital goods to services, such as T-shirts, mp3s, and tutoring products. It process debit and credit cards for payments. Ribbon Payments, Inc. was formerly known as Kout Inc. and changed its name to Ribbon Payments, Inc. in November 2012. The company was incorporated in 2011 and is based in San Francisco, California.

Flurry

Venture Round in 2013
Flurry is an application that provides analytics for businesses to monitor the trends and habits of mobile users across multiple mobile applications. Flurry’s mobile analytics solution enables businesses to understand how consumers interact with their mobile applications. Over 125,000 companies use Flurry’s analytics platform in more than 400,000 applications to measure audience reach, engagement, retention, conversions, revenue, and more. The service is completely free, takes just five minutes for basic integration, and is continuously updated with the industry's advanced features. Flurry Analytics is available for iOS, Android, Windows Phone, HTML5, hybrid apps, mobile/web, Blackberry, and JavaME.

Achates Power

Series D in 2017
Achates Power specializes in the fields of combustion engine development, clean diesel, and 2-stroke oil control management. The company is on a mission to build better, more efficient engines, the company has an experienced staff of engineers and scientists focused on applying their proven technical know-how and expertise, coupled with the industry's leading-edge testing, simulation, and analysis tools. it was founded in 2004 and headquartered in San Diego, California.

Restoration Robotics

Venture Round in 2016
Restoration Robotics is a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing a state-of-the-art image-guided system (ARTAS™ System) that enables follicular unit extraction.

Sera Prognostics

Series A in 2011
Sera Prognostics, Inc., a biotechnology company, develops diagnostic tests for the early prediction of a woman’s individualized risk of premature birth, preeclampsia, and other pregnancy complications. It focuses on addressing the economic and healthcare burden that premature birth places on infants, their families, and society. Sera Prognostics, Inc. was founded in 2008 and is based in Salt Lake City, Utah.

Open Silicon

Series D in 2007
Open-Silicon provides leading edge SoC and Custom IC design, open market IP integration, and high-quality silicon manufacturing services to customers worldwide. As a fabless company, Open-Silicon focuses on delivering the most cost-effective, predictable and reliable custom SoC solutions. The company partner with customers using flexible models that sometimes include full turnkey development from spec handoffs, and sometimes include only manufacturing services to take advantage of volume foundry, test, and packaging pricing. Since its founding in 2003, the company has focused on raising the bar on SoC execution, measuring the quality of engineering work and ability to hit customer schedules and reporting that to the board of directors at every board meeting.

Xirrus

Series D in 2009
Xirrus, Inc. manufactures and markets wireless networking products. The company offers indoor enclosures, snap-on covers, manufacturing rated enclosures, I-beam mounting kits, and outdoor enclosures; and products for improving security and minimizing the risk in deploying 802.11n wireless networks. It also provides Wi-Fi Array, a wireless networking device that integrates radios, high-gain directional antenna systems, multi-gigabit switches, controllers, firewalls, threat sensors, and embedded spectrum analyzers. In addition, the company offers power over gigabit Ethernet (PoGE) products; and a Management System, which offers a platform for the central management of a Wi-Fi Array network. It serves general enterprise, higher education, K-12 education, conference centers, hospitality, and manufacturing markets. The company was founded in 2004 and is headquartered in Thousand Oaks, California.

Bivio Networks

Venture Round in 2008
Founded in 2000, Bivio Networks is dedicated to providing leading networking products that enable government agencies and service providers to control, monitor, and secure critical network infrastructure. A leader in cyber intelligence, cyber security and network control solutions, Bivio has deployed its products in a wide range of solutions. Bivio’s global customer base includes leading intelligence agencies, military organizations and service providers. Bivio is privately-held and is headquartered in the San Francisco Bay Area with office locations worldwide. Specialties Cyber Security, Cyber Intelligence, Deep Packet Inspection (DPI) Networking Systems, Mass Metadata Extraction and Analysis, Data Retention System, Cyber Investigation, network probe

Restoration Robotics

Series B in 2007
Restoration Robotics is a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing a state-of-the-art image-guided system (ARTAS™ System) that enables follicular unit extraction.

Pivot3

Venture Round in 2013
Global Hyper-Converged Infrastructure

Follica

Series A in 2008
Follica, Inc. develops a treatment system for hair loss in adult humans. It offers an in-office treatment proprietary device that disrupts the skin and creates new hair follicles; and at-home treatment system that delivers compounds directly to the scalp for a daily routine. Follica, Inc. was incorporated in 2005 and is based in Boston, Massachusetts. Follica, Inc. operates as a subsidiary of PureTech Health plc.

Pivot3

Series G in 2015
Global Hyper-Converged Infrastructure

RHK

Series A in 2000
RHK is the leading industry market research and consulting firm specializing in the analysis of advanced technologies for the public telecommunications network. The company provides subscription services and custom consulting to technology vendors, service providers, component suppliers and the investment community.

Ophthonix

Series C in 2005
Ophthonix, Inc. manufactures and markets high resolution spectacle lenses for vision assessment and correction applications. It offers its high resolution lenses for single vision spectacle lenses for the correction of myopia, hyperopia, and mild astigmatism; and progressive addition spectacle lenses. The company sells its products through practitioners in the United States and European countries. Ophthonix, Inc. was founded in 2000 and is based in Vista, California.

Invuity

Private Equity Round in 2015
Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.

Neuronetics

Series E in 2011
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

MicroCHIPS

Venture Round in 2010
Microchips Biotech, Inc. is dedicated to improving the lives of patients by revolutionizing drug delivery. Our proprietary microchip-based implant can store and release precise doses of drugs over months and years. The implant, which is placed under the skin by a trained physician during a simple office procedure using local anesthesia, can be wirelessly activated or deactivated by a physician or patient, without requiring removal. In addition, physicians can wirelessly modify the frequency or dose of the drug to meet the individual needs of each patient.

Welltok

Series D in 2015
Welltok is a data-driven, enterprise SaaS company that delivers the healthcare industry’s leading consumer activation platform. Welltok’s solutions empower health plans, employers, providers, and public entities to connect consumers with personalized health improvement resources, making it easy and rewarding for consumers to complete actions that optimize their health and wellbeing. The company was founded in 2009 and headquartered in Denver, Colorado.

Joyus

Series C in 2015
Joyus is a startup that's helping shoppers discover goods via short-form videos. Welcome to Joyus, a brand new online shopping experience to help you discover and buy the things you'll love. Our purpose at Joyus is to help delight and transform your shopping experience by harnessing the power of video. Each week our amazing curators share their special apparel, beauty and lifestyle finds with you and then show you how to make them work for you. Each item is available for sale for a limited time through our exclusive video sales platform, making it easy for you to buy the things you love. You can also easily share these videos with your friends on Facebook and Twitter with just a simple click. Whether it's uncovering the latest trends, bringing our favorite brands with you, or solving a dilemma - all our video sales share one thing in common. We believe that sharing our authentic passion and finds with you is the key to creating a truly Joyus shopping experience online.

Xenon Pharmaceuticals

Venture Round in 2001
XENON® is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform, which we refer to as Extreme Genetics. Our product candidates are based on genetic insights derived from our research of families where individuals exhibit severe traits, or phenotypes. We apply our expertise to predict which phenotypes are caused by single-gene defects. By identifying and characterizing the single-gene defects responsible for such severe phenotypes, we gain valuable insights into their function in human biology and their potential as drug targets. Given that these targets are often involved in diseases beyond the rare genetic disorders in which they are first identified, we are developing proprietary product candidates to treat both orphan as well as more prevalent diseases

Spiration

Series F in 2006
Spiration, Inc., doing business as Olympus Respiratory America, develops medical devices for the treatment of air leaks and lung diseases. The company was founded in 1999 and is based in Redmond, Washington. As of 2010, Spiration, Inc. operates as a subsidiary of Olympus America Inc.

Satori Pharmaceuticals

Venture Round in 2012
Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of disease-modifying therapies for Alzheimer's disease, Parkinson's disease and other neurodegenerative disorders.

Cardiac Dimensions

Series D in 2007
Cardiac Dimensions, Inc., a medical device company, engages in the development of minimally invasive treatment modalities to address heart failure and related cardiovascular conditions. The company develops Carillon Mitral Contour System, a permanent implant for the treatment of functional mitral regurgitation. The company was incorporated in 2000 and is based in Kirkland, Washington with additional operations in Sydney, Australia and Offenbach, Germany.

Joyus

Series B in 2013
Joyus is a startup that's helping shoppers discover goods via short-form videos. Welcome to Joyus, a brand new online shopping experience to help you discover and buy the things you'll love. Our purpose at Joyus is to help delight and transform your shopping experience by harnessing the power of video. Each week our amazing curators share their special apparel, beauty and lifestyle finds with you and then show you how to make them work for you. Each item is available for sale for a limited time through our exclusive video sales platform, making it easy for you to buy the things you love. You can also easily share these videos with your friends on Facebook and Twitter with just a simple click. Whether it's uncovering the latest trends, bringing our favorite brands with you, or solving a dilemma - all our video sales share one thing in common. We believe that sharing our authentic passion and finds with you is the key to creating a truly Joyus shopping experience online.

Exalt Communications

Series C in 2009
Exalt Communications provides wireless backhaul systems and interconnect solutions. Its solutions include microwave radio systems designed to solve the bottlenecks within the last mile, middle mile, and first mile sections of the network. The company serves service providers, mobile carriers, municipal Wi-Fi mesh networks, and emerging carriers and wireless ISPs, as well as education, healthcare, enterprise, government, public safety and emergency response, and industrial sectors. Exalt Communications was founded in 2004 and is based in Campbell, California
PrimeraDx, Inc. offers multiplexed infectious disease assays. It provides Scalable Target Amplification Routine technology, which is a method for simultaneous quantitative measurement of multiple target nucleic acids. The company also offers ViraQuant, a multiplexed assay providing quantitative and simultaneous measurement of viruses; and FungiQuant Yeast and FungiQuant Mold, which are fungal panels for mycology testing. Its products are used in miRNA, DNA methylation, quantitative genotyping, gene expression, and viral load measurement applications. PrimeraDx, Inc. was founded in 2004 and is based in Mansfield, Massachusetts.

Nanostim

Venture Round in 2012
Nanostim is an early-stage medical device company working to prevent more than 100,000 annual complications related to pacemakers. Nanostim has assembled a world-class team of experienced medical device engineers to help bring this exciting technology to the marketplace.

Varolii

Series D in 2011
Varolii is the market and technology leader in proactive outbound communications. Its on-demand communication software and services help organizations more effectively reach and interact with their customers and employees, getting the best result from every interaction. By automating the processes required for personalized communications such as flight cancellation notices, fraud detection alerts and prescription pick-up reminders, Varolii helps its clients reduce operational costs, increase contact center efficiency, and get more out of their existing IT investments. More than 380 companies, including many of the largest U.S. banks, airlines, wireless carriers, utilities, and healthcare organizations trust Varolii to send 4 million communications every business day. Varolii is headquartered in Seattle with offices in the Boston and Denver metropolitan areas. Varolii was acquired by Nuance Communications (NASDAQ: NUAN) in October 2013 for an undisclosed price.

Spredfast

Series B in 2011
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Archus Orthopedics

Series B in 2003
Archus Orthopedics is focused on the development of implants to treat a variety of spine disorders that result from degenerative changes in the facet joints. Archus Orthopedics offers Total Facet Arthroplasty System, a spinal implant that is designed for patients suffering from lumbar spinal stenosis. Archus Orthopedics was acquired by Facet Solutions in November 2009. Archus Orthopedics was founded in 2001 and is based in Redmond, Washington.

IntraLase Corporation

Venture Round in 2000
IntraLase Corporation is a leader in the first step of LASIK surgery, the most common means of surgical vision correction. They design, develop and market a laser, related software and disposable devices used to create a cut of tissue across the cornea of a patient’s eye, or a corneal flap, which is the first step in LASIK surgery. Their advanced laser technology improves the safety, precision and visual acuity of LASIK surgery by providing a computer-controlled laser solution as an alternative to the traditional method of creating the corneal flap using a hand-held mechanical, metal-bladed device called a microkeratome. They believe their product offering will become the new standard of care for corneal flap creation. As of April 2, 2007, IntraLase Corp. was acquired by Advanced Medical Optics Inc.

Optimizely

Series A in 2013
Optimizely is provides customer experience optimization, allowing businesses to dramatically drive up the value of their digital products, commerce, and campaigns through its best in class experimentation software platform. By replacing digital guesswork with evidence-based results, Optimizely enables product and marketing professionals to accelerate innovation, lower the risk of new features, and drive up the return on investment from digital by up to 10X. Over 26 of the Fortune 100 companies choose Optimizely to power their global digital experiences. Optimizely’s impressive customer list includes eBay, FOX, IBM, The New York Times, and many more global enterprises. Optimizely was founded in 2009 and is headquartered in San Francisco, California.

Ciena

Series B in 1994
Ciena is the network specialist. They collaborate with customers worldwide to unlock the strategic potential of their networks and fundamentally change the way they perform and compete. With focused innovation, Ciena brings together the reliability and capacity of optical networking with the flexibility and economics of Ethernet, unified by a software suite that delivers the industry's leading network automation. They routinely post recent news, financial results and other important announcements and information about Ciena on their website.

Brecis Communications

Series B in 2001
BRECIS Communications, a communications company focused on leading-edge, broadband multi-service network processor architectures.

DataRPM

Series A in 2014
DataRPM provides a Cognitive Data Science platform on the cloud or on-premises for enterprises to build data products for Predictive Analytics and Recommender Systems. Enterprises across the globe are using DataRPM to digitally transform their businesses in the core areas of Predictive Maintenance, Product Recommendations, Content Recommendations, Churn Predictions, and Conversion Predictions. DataRPM prides itself on delivering the fastest and scalable automated data science platform with a natural language question-answering interface which guarantees a return on investment for their customers and turns everyone in the organization into citizen data scientists.

Obalon Therapeutics

Series C in 2012
Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology. Located in San Diego, California, the technical team at Obalon has a long history of working closely with leading clinicians to develop innovative medical products that revolutionize the treatment of chronic disease. As a company, they believe in the fundamental value of imagination and invention, combined with rigorous testing and analysis, to ensure the highest levels of safety and performance. The result is a user-focused approach that deploys the power of advanced technological thinking to support clinical treatment objectives. It was founded in 2008.

USGI Medical

Series B in 2003
USGI Medical, Inc. engages in the development of technologies that enable surgeons and gastroenterologists to perform procedures through the body's natural passageways. The company offers specialized tools to perform minimally invasive procedures through a patient's mouth or other natural orifices. It offers its products obesity, natural orifice translumenal endoscopic surgery, and gastroesophageal reflux disease. The company was incorporated in 2001 and is based in San Clemente, California.

Silicon Optix

Series C in 2004
Silicon Optix is a fabless semiconductor company, supplier of warping integrated circuit (IC) technology – eWARP™. eWARP digital distortion correction allows manufacturers to complement optics with sophisticated electronics imaging in order to achieve superior system designs and add new compelling features to products while reducing cost and complexity of optical systems. Silicon Optix has the only mainstream geometry processing IC in volume production to date. Over seven years of research and development invested in IC design, system design and optics have given Silicon Optix the expertise to be the leader in this emerging technology with large market opportunities.

The RealReal

Series B in 2013
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Welltok

Series C in 2014
Welltok is a data-driven, enterprise SaaS company that delivers the healthcare industry’s leading consumer activation platform. Welltok’s solutions empower health plans, employers, providers, and public entities to connect consumers with personalized health improvement resources, making it easy and rewarding for consumers to complete actions that optimize their health and wellbeing. The company was founded in 2009 and headquartered in Denver, Colorado.

Convey Computer

Series B in 2009
Convey Computer offers a hybrid core computer for the oil and gas, financial analytics, and bioinformatics markets. The comp[any delivers decades of experience and intellectual assets to performance problem-solving. Its executive and design teams all come from successful backgrounds of building computer companies, most notably Convex Computer Corporation and Hewlett-Packard.

Splice Machine

Series B in 2014
Splice Machine is a data platform that offers offline, and batch analysis, and powers intelligent applications for operational workflows. Splice Machine is disrupting the $30 billion traditional database world with the open-source dual-engine RDBMS for mixed operational and analytical workloads, powered by Apache Hadoop and Apache Spark. The Splice Machine RDBMS executes operational workloads on Apache HBase® and analytical workloads on Apache Spark. Splice Machine makes it easy to develop and create modern, real-time, scalable applications, or to offload operational and analytical workloads from expensive Oracle, Teradata, and Netezza systems. Typical use cases are ETL, operational reporting, or real-time applications.

Labrys Biologics

Series A in 2013
Labrys Biologics Inc., a company focused on treatments for chronic migraine. Labrys Biologics has acquired worldwide rights to RN-307 from Pfizer Inc. RN-307 is an antibody for the treatment of chronic migraine.